bf/NASDAQ:CGEM_icon.png

NASDAQ:CGEM

Cullinan Oncology

Add to Watchlist
  • Stock

8.52

+2.90%

1.22

USD last updated 11/08 02:03:55

Last Close

7.29

08/08 20:01

Market Cap

923.88M

Beta: 0.10

Volume Today

456.26K

Avg: 224.28K

PE Ratio

−4.92

PFCF: −5.42

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its p...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -6-4-22462019-06-292020-06-292021-11-092023-11-082024-11-13

    Revenue (Estimate*)

    -40M-20M20M40M2019-06-292020-06-292021-11-092023-11-082024-11-13

    *Estimate based on analyst consensus